Domainex Ltd Announces Investment Round to Progress Its TBK1/IKKe and Epigenetic Programs
2/14/2013 10:21:02 AM
More...
|
Domainex Ltd Launches Discovery STAR Award to Support Early Academic Drug Discovery
1/22/2013 11:10:06 AM
More...
|
Domainex Ltd Researchers Identify Small-Molecule Inhibitors of TBK1/IKKepsilon Affecting IL-17 Signaling
11/5/2012 12:01:39 PM
More...
|
UCB, Inc. (UCBJF.PK) and Domainex Ltd Collaboration Provides Valuable Information on Cancer Drug Target
3/12/2012 11:03:55 AM
More...
|
Domainex Ltd Awarded Technology Strategy Board Funding to Support its Research into a Novel Cancer Drug
11/1/2011 9:13:48 AM
More...
|
Domainex Ltd to Invest in its Drug Discovery Services and Internal Oncology Pipeline in 2011
3/7/2011 8:59:46 AM
More...
|
Domainex Ltd Wins Genesis Award for its Work in Supporting Translational Research
12/15/2010 10:34:00 AM
More...
|
Domainex Ltd Collaborates with Sigma-Aldrich Corporation (SIAL) to Advance the Study of Epigenetic Proteins Involved in Cancer and Stem Cell Biology
11/15/2010 1:25:39 PM
More...
|
Domainex Ltd Announces the Appointment of Joanne McCudden As Head of Business Development
9/22/2010 11:09:19 AM
More...
|
Domainex Ltd Lead Optimisation Services Facilitate A New Cancer Drug Discovery Program
4/7/2010 12:28:43 PM
More...
|
|